Pentadecanoic acid, 5’-MTA, ADMA, and glutamine were identified as potential biomarkers of DS, while ABC transporters and the mTOR signaling pathway likely make significant contributions toward DS development. Here, ABCG2 is linked to Dravet syndrome.